| Trial ID: | L4329 |
| Source ID: | NCT00168519
|
| Associated Drug: |
Nitroprusside, Pentalong, Imdur, Aicar, Isoptin
|
| Title: |
Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: nitroprusside, pentalong, imdur, AICAR, isoptin
|
| Outcome Measures: |
Primary: glucose metabolism, 3 hours | Secondary: 3 hours post
|
| Sponsor/Collaborators: |
Sponsor: Baker Heart Research Institute | Collaborators: National Health and Medical Research Council, Australia|Hoffmann-La Roche|Life for a Child Program, Diabetes Australia
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2002-10
|
| Completion Date: |
2009-04
|
| Results First Posted: |
|
| Last Update Posted: |
2009-12-15
|
| Locations: |
Baker Heart Research Institute, Melbourne, Victoria, 8008, Australia
|
| URL: |
https://clinicaltrials.gov/show/NCT00168519
|
